Within the kidney, pCpG-Muγ treatment induced expression of APOL1 mRNA and APOL1 protein synthesis primarily in podocytes, supporting the idea that podocytes are crucial in at least some APOL1-nephropathies (Beckerman et al., 2017). The gene discussed is APOL1; the disease is kidney disorder.